Publications

04 Mar 2002
Research & Ideas

Don’t Lose Money With Customers

at the market level, then translate these into strategies at the market segment level. A paper mill's marketing strategy, for instance, might call for selling newsprint to the publishing industry segment and paperboard to the packaging... View Details

Keywords: by Peter K. Jacobs

02 Nov 2010
First Look

First Look: November 2, 2010

a commercial entity (images captured and uploaded from personal cell phone cameras), the news industry landscape became freewheeling and individualistic. The straight-line model of content generator to distributor to reader was gone.... View Details

Keywords: Sean Silverthorne

January 2007 (Revised January 2007)
Background Note

Note on the U.S. Food and Drug Administration

By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller

Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure. View Details

Keywords: Health; Governance Compliance; Policy; Product Development; Government and Politics; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States

January 2021
Supplement

Barbara Krakow Gallery (B): Art and the Pandemic

By: José B. Alvarez and David Lane

Updates (A) case by describing the early impact of the COVID-19 pandemic on the art market, the renaming of the gallery as the Krakow Witkin Gallery, and the response of its partners and staff to the pandemic. View Details

Keywords: Art Market; COVID-19; Arts; Business Model; Change Management; Trends; Communication; Customer Focus and Relationships; Human Resources; Marketing; Distribution Channels; Outcome or Result; Health Pandemics; Fine Arts Industry

July 1997
Case

We've Got Rhythm! Medtronic Corporation's Cardiac Pacemaker Business

By: Clayton M. Christensen

Illustrates how a new management team at Medtronic's Cardiac Pacemaker business reversed a steep decline in market share by adopting certain management principles for new product development: clarifying strategy, aggregating project planning, accommodating the number... View Details

Keywords: Management Teams; Innovation Strategy; Innovation and Management; Product Development; Health; Technology; Change Management; Medical Devices and Supplies Industry; United States

Summer 2020
Article

Is It Time to Rethink Globalized Supply Chains?: The COVID-19 Pandemic Should Be a Wake-up Call for Managers and Prompt Them to Consider Actions That Will Improve Their Resilience to Future Shocks

By: Willy C. Shih

The COVID-19 pandemic has exposed the complex interdependencies of globalized supply chains. While these global multistage production networks had spread during a relatively benign environment of falling trade barriers and increasing interdependencies among countries,... View Details

Keywords: Supply Chains; Pandemic; Resilience; Supply Chain Management; Supply Chain; Global Range; Health Pandemics; Disruption; System Shocks; Crisis Management; Manufacturing Industry; United States; Asia; Europe; China

Find at Harvard

Register to Read

09 Mar 2020
Research & Ideas

Warring Algorithms Could Be Driving Up Consumer Prices

that is freely available online—as an input for calculating price changes. In a given industry or category, the most technologically sophisticated company is able to continually undercut its rivals by updating prices more frequently than... View Details

Keywords: by Kristen Senz; Retail

03 Mar 2008
Research & Ideas

Marketing Your Way Through a Recession

Industrial customers prefer to see products and services unbundled and priced separately. Gimmicks are out; reliability, durability, safety, and performance are in. New products, especially those that address the new consumer reality and... View Details

Keywords: by John Quelch

November 2023 (Revised April 2024)
Case

BiomX: Bringing Phage Back to the Stage

By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud

In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details

Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Biotechnology Industry

November 2007
Case

Antegren: A Beacon of Hope

By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann

The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details

Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Biotechnology Industry

December 2021
Case

Pairwise

By: José B. Alvarez and Annelena Lobb

Pairwise discusses the strategic approach of a company aiming to “snackify” fruits and vegetables by using CRISPR-Cas9 gene editing to create nutritious, bite-sized foods that could compete with packaged snacks. The company is confronting a number of challenges,... View Details

Keywords: Gene Editing; GMO; Food; Nutrition; Competition; Market Entry and Exit; Public Opinion; Competitive Strategy; Consumer Behavior; Food and Beverage Industry

13 Mar 2014
Research & Ideas

Can We Get To Where We Need To Go?

those who care about the renewed, continued competitiveness of the United States," he told attendees who gathered recently at the national summit held at HBS, America on the Move: Transportation and Infrastructure for the 21st... View Details

Keywords: by Dina Gerdeman; Transportation; Air Transportation; Auto

February 2020
Teaching Note

Theranos: Who Has Blood on Their Hands? (A) and (B)

By: Nien-he Hsieh and Christina R. Wing

Teaching Note for HBS Nos. 619-039 and 320-091. View Details

Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Lawsuits and Litigation; Medical Devices and Supplies Industry; California; United States

24 Apr 2018
First Look

First Look at New Research and Ideas, April 24, 2018

In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare... View Details

Keywords: Sean Silverthorne

April 1993 (Revised November 1994)
Case

Chiron Corp.

By: Steven C. Wheelwright

Pablo Valenzuela, vice president of R&D at Chiron Corp., faces several choices for how to allocate scarce resources across several promising projects. These choices will determine Chiron's position in several emerging biotechnology and diagnostic markets, including... View Details

Keywords: Health Testing and Trials; Research and Development; Failure; Business Strategy; Joint Ventures; Strategic Planning; Opportunities; Product Development; Biotechnology Industry; California

Find at Harvard

March 2023
Teaching Note

VideaHealth: Building the AI Factory

By: Karim R. Lakhani

Teaching Note for HBS Case No. 621-021. The case “VideaHealth: Building the AI Factory” examines the creation of dental startup VideaHealth (Videa) and the development of its artificial intelligence (AI)-led business strategy through the eyes of founder and CEO Florian... View Details

Keywords: AI and Machine Learning; Applications and Software; Business Model; Marketing Strategy; Product Development; Health Industry; Health Industry

October 2014 (Revised July 2016)
Supplement

Gilead: Hepatitis C Access Strategy (B)

By: V. Kasturi Rangan

While the "Gilead: Hepatitis-C Access Strategy (A)" case (HBS No. 515-025) poses questions on what the company should do with respect to hard-hit countries like Egypt and India, the (B) case provides the answer. In both cases, the company chose to pursue a proactive... View Details

Keywords: Emerging Markets; Health Industry; Health Industry